幹細胞関連試薬 培養培地

弊社が販売する試薬は全て研究用です。為替変動等の影響により、ページ内に記載されている料金等の金額は全て参考につき、詳細はお気軽にお問い合わせください。
分子生物学試薬 ・ キットのトップページへ戻る
関連製品 ・ サービスへ進む
お問い合わせ ・ ご注文へ進む
注目最新情報:抗原、レセプターの特異的蛍光標識試薬 / ・ 新型コロナウイルス (SARS-CoV-2)関連製品

This service / product is supplied by Creative Biolabs社ロゴ etc.

目次

  • 幹細胞培養
  • 幹細胞分化
  • 幹細胞同定 ・ 保存
  • 参考価格

製品の詳細はリンク先をご覧いただき、サンプルのご用命 ・ お問い合わせ ・ ご注文は当サイトの問い合わせフォームよりお気軽にご連絡ください。

幹細胞培地

型 番 製品名
詳細 ・ 特長
ITS-0622-YT18 I-O™ Mesenchymal Stem Cell Media, Xeno-Free (XF) (CAT#: ITS-0622-YT18)
This medium is optimized for the expansion of human mesenchymal stem cells. There is purified Human Serum Albumin (HSA) in the media. It is is ready to use or it may be used with additional cytokine/growth factor supplements for the desired cell culture application. MSCs grown under Xeno-Free (XF) conditions should be grown on extracellular matrix (ECM) protein-coated plates.
ITS-0622-YT356 I-O™ Essential 8 Medium Kit (CAT#: ITS-0622-YT356)
I-O™ Essential 8 Medium is a Xeno-Free (XF) and feeder-free medium specially formulated for the growth and expansion of human pluripotent stem cells (PSCs). I-O™ Essential 8 Medium Kit contains E8 Basal medium and 25X E8 Supplement, providing a simpler medium with low-protein formulation for the culture of pluripotent stem cells. This kit has been tested on human embryonic stem (ES) cells and human induced pluripotent stem (iPS) cells. iPSCs maintain growth without any signs of karyotypic abnormalities and maintain differentiation of all three germ line lineages.

幹細胞分化培地

型 番 製品名
詳細 ・ 特長
ITS-0622-YT21 I-O™ Mesenchymal Stem Cell Chondrogenic Differentiation Media (CAT#: ITS-0622-YT21)
This medium is a base medium for the differentiation of MSCs into chondrocytes. All the components have been selected and optimized for human, mouse, and rat MSC chondrogenesis. This medium requires supplements (not included), such as human/mouse/rat chondrogenic supplement or user-defined cytokines and growth factors to induce chondrogenesis. Differentiation to mature chondrocytes is seen between 14 and 28 days.
ITS-0622-YT42 I-O™ hMSCs Osteogenic Differentiation Medium (CAT#: ITS-0622-YT42)
This medium is a Serum-Free (SF) complete medium optimized for the osteogenic differentiation of human adipose-derived mesenchymal stem/stromal cells (MSCs) and human amniotic fluid stem cells (AFSCs). It is ready to use and can be supplemented with additional cytokines/ growth factors for desired applications. Differentiation to mature chondrocytes is seen between 14 and 21 days.
ITS-0622-YT20 I-O™ Mesenchymal Stem Cell Osteogenic/Adipogenic Differentiation Media (CAT#: ITS-0622-YT20)
Mesenchymal stem cells (MSCs) can differentiate into adipocytes, osteoblasts, myocytes, and chondrocytes in vivo and in vitro. This medium is a base medium for the differentiation of MSCs into osteocytes or adipocytes. Creative Biolabs has developed a series of mediums and supplements for cell culture, expansion and differentiation. This medium requires supplements (not included), such as osteogenic supplement, adipogenic supplement, or user-selected cytokines and growth factors. Differentiation to mature osteocytes/adipocytes is seen between 2-3 weeks.
型 番 製品名
詳細 ・ 特長
BY162499 Y 27632 dihydrochloride
Biosynth社
Specific inhibitor of Rho-associated ROCK kinases which supresses tumour cell invasion and affects cell proliferation, differentiation and motility. The compound competes with ATP for binding to the kinase catalytic site and inhibits phosphorylation of ROCK substrates. This inhibitor was also shown to attenuate neuronal death after transient retinal ischemia and to possess protective effects on human embryonic stem cells.
型 番 製品名
詳細 ・ 特長
FB32804 SB 431542
Biosynth社
Inhibitor of activin receptor-like kinases (ALK4, ALK5 and ALK7), members of TGFβ type I receptor family. Blocks activin- and TGFβ-mediated signaling and phosphorylation of Smad2 downstream. Suppresses tumor-promoting and tumor-suppressing effects of TGFβ. Promotes differentiation of human embryonic stem cells (hESCs), whilst sustaining mouse ESCs in the undifferentiated state.
型 番 製品名
詳細 ・ 特長
FD43329 CHIR 99021
Biosynth社
Potent and selective inhibitor of the glycogen synthase kinase GSK-3. Promotes cell renewal in embryonic stem cells by modulating Notch, MAPK and TGF-β signalling pathways, which are involved in pluripotency. It also affects the Wnt/β-catenin pathway and alters expression of genes coding for proteins, epigenetic regulatory elements and non-coding RNAs. The combination of CHIR 99021 and basic fibroblast growth factor (bFGF) allows long-term self-renewal in adult mouse retinal progenitor cells.

参考価格

お気軽にお問い合わせください。


幹細胞関連試薬 無血清培地のお問い合わせ ・ ご注文

    ・当ウェブサイトは常時SSL化(HTTPS化)されております。お問い合わせ内容は暗号化され、より安全にご利用いただけます。
    ・下記フォームのご入力が面倒な方は、 sales@biologica.co.jp へメールでお送り頂いても結構です。


    見積もりご注文お問い合わせ


    他社を経由してのご購入をご希望の場合や、請求書等の宛名に特別な注意が必要な場合は最下部の特記事項欄にご記入ください。






    お願い:送信ができない場合や、自動返信メールが届かない場合は、大変お手数ですがsales@biologica.co.jpへ直接メールをお送りください。